---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-024807"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2021-11-02T23:59:59+00:00"
generated_at: "2026-06-28T15:27:16.956396+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne Q1 FY2022 revenue $257.7M, organic growth 21%; adjusted EPS $1.83 vs $1.43

## Summary
- Q1 FY2022 revenue $257.7M, organic growth 21% (reported 26%).
- GAAP EPS $1.69, adjusted EPS $1.83 vs $1.43 prior year.
- Protein Sciences organic growth 26% (third consecutive quarter >20%).
- China revenue grew over 50% organic; North America and Europe at least 20%.
- Board declared $0.32 per share dividend payable Nov 26, 2021 to holders of record Nov 12.

## SEC filing metadata
- accession: 0001437749-21-024807
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2021-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000143774921024807/0001437749-21-024807-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000143774921024807/tech20211101_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-024807
- JSON: https://secwatch.observer/filing/0001437749-21-024807.json
- Plain text: https://secwatch.observer/filing/0001437749-21-024807.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.